GlassScriptPhysician profile
Oliver Ghalambor
NPI 1710008966
$811.98
in general payments reported to CMS, 2019-2025
10 companies · $93.39 in 2025
The $93.39 reported for 2025 was less than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $30.50 · 2022: $229 · 2023: $95.14 · 2024: $364 · 2025: $93.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $379.66 | 2022-2025 | Dysport |
| Mml US, INC. | $160.62 | 2024 | Reactiv8 |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Fidia Pharma USA INC. | $38.03 | 2023-2025 | Hymovis, Triluron |
| Depuy Synthes Sales INC. | $32.09 | 2022-2025 | Orthovisc |
| Lundbeck LLC | $32.02 | 2023-2024 | Vyepti |
| Abbvie INC. | $20.98 | 2025 | |
| Spinal Simplicity, LLC | $20.13 | 2024 | Ha Minuteman G3-R |
| Allergan, INC. | $18.56 | 2021 | |
| Stimwave Technologies Incorporated | $11.94 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oliver Ghalambor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.